The Ebola virus disease epidemic in West Africa is the largest on record, responsible for over 28,599 cases and more than 11,299 deaths 1 . Genome sequencing in viral outbreaks is desirable to characterize the infectious agent and determine its evolutionary rate. Genome sequencing also allows the identification of signatures of host adaptation, identification and monitoring of diagnostic targets, and characterization of responses to vaccines and treatments. The Ebola virus (EBOV) genome substitution rate in the Makona strain has been estimated at between 0.87 × 10 −3 and 1.42 × 10 −3 mutations per site per year. This is equivalent to 16-27 mutations in each genome, meaning that sequences diverge rapidly enough to identify distinct sub-lineages during a prolonged epidemic 2-7 . Genome sequencing provides a high-resolution view of pathogen evolution and is increasingly sought after for outbreak surveillance. Sequence data may be used to guide control measures, but only if the results are generated quickly enough to inform interventions 8 . Genomic surveillance during the epidemic has been sporadic
owing to a lack of local sequencing capacity coupled with practical difficulties transporting samples to remote sequencing facilities 9 . To address this problem, here we devise a genomic surveillance system that utilizes a novel nanopore DNA sequencing instrument. In April 2015 this system was transported in standard airline luggage to Guinea and used for real-time genomic surveillance of the ongoing epidemic. We present sequence data and analysis of 142 EBOV samples collected during the period March to October 2015. We were able to generate results less than 24 h after receiving an Ebola-positive sample, with the sequencing process taking as little as 15-60 min. We show that real-time genomic surveillance is possible in resource-limited settings and can be established rapidly to monitor outbreaks.
Conventional sequencing technologies are difficult to deploy in developing countries, where availability of continuous power and cold chains, laboratory space, and trained personnel is restricted. In addition, some genome sequencer instruments, such as those using optical readings, for example the Illumina platform, require precise microscope alignment and repeated calibration by trained engineers 7, 10 . Recently, a new highly portable genome sequencer has become available. The MinION (Oxford Nanopore Technologies, Oxford, UK) weighs less than 100 g. Data are read off the MinION from a laptop via a Universal Serial Bus (USB) port from which the instrument also draws power. The MinION works by taking frequent electrical current measurements as a single strand of DNA passes through a protein nanopore at 30 bases per second. DNA strands in the pore disrupts ionic flow, resulting in detectable changes in current that is dependent on the nucleotide sequence. Because the MinION detects single molecules it has a much higher error rate (between 10-20% 11, 12 ) than high-throughput instruments that read clonal copies of DNA molecules. Single-molecule sequencing has the advantage of being able to read extremely long molecules of DNA (50 kb or longer 12, 13 ). In order to generate accurate sequences, genomic regions must be read many times, with errors eliminated through consensus averaging. This system has previously been used to investigate a bacterial outbreak, but not yet a viral outbreak 14 .
We designed a laboratory protocol to permit EBOV genome sequencing on the MinION that employed a targeted reverse transcriptase polymerase chain reaction (RT-PCR) in order to isolate sufficient DNA for sequencing. We considered and rejected an alternative approach, that of total RNA sequencing, as this approach also amplifies humanderived transcripts and dilutes viral signal 15 . We designed a panel of 38 primer pairs that would span the EBOV genome (Extended Data Fig. 1a , Supplementary Table 1 ). In pilot experiments at the Defence Science and Technology Laboratory (Dstl) Porton Down, UK, we sequenced a historic Zaire Ebolavirus using MinION as well as the Illumina MiSeq. Due to difficulties obtaining equal balancing of each of the 38 amplicon pairs only 65.7% of the EBOV genome was covered by at least 25 reads, compared with 87.4% on Illumina. However, nucleotide variants in those highly covered regions were concordant with those obtained from Illumina sequencing, with the exception of a single variant in a homopolymeric region. MinION sequencing currently cannot easily resolve the length of homopolymers of 5 bases or greater 16 .
Next we designed a genome surveillance system that could be transported to West Africa. The system consisted of three MinION instruments (Oxford Nanopore Technologies, UK), four laptops, a thermocycler, a heat block, pipettes and sufficient reagents and consumables to perform sequencing (a full list of equipment is shown in Extended Data Fig. 2 ). We were able to pack this into less than 50 kg of standard airline travel luggage ( Fig. 1a ). We initially installed the genome surveillance system in the European Mobile Laboratory in Donka Hospital in Conakry, Guinea (Fig. 1b ). Later on, the equipment was moved to a dedicated laboratory, located within the Coyah Ebola Treatment Unit (Fig. 1c, d ).
We started sequencing genomes within 2 days of arriving in Guinea. We found early on that we were able to reliably generate long amplicons (around 2 kb in length) using primer pairs ( Supplementary Table 4 ) in different combinations (Extended Data Fig. 1b , c). Using as few amplicons as possible significantly reduces effort when preparing samples. We found a combination of 11 amplicons that reliably amplified > 97% of the EBOV genome.
We developed a bioinformatics approach that would yield accurate genotypes, and validated this using Makona virus samples from a previous study 3 . The bioinformatics workflow is detailed in the Methods and summarized in Extended Data Fig. 3 . This validation process demonstrated that our bioinformatics analysis approach was robust. We compared our consensus sequences to those generated using Illumina Letter reSeArCH sequencing and found that our approach was highly concordant, with no false positive variant calls. In several cases, we were unable to determine variants because they fell either within the primer binding region, or they were outside of the regions of the EBOV genome covered by our amplicon set (Extended Data Fig. 4a ). These positions are represented as ambiguous nucleotides in the final consensus sequences used for analysis. Despite these masked positions, phylogenetic inference showed that samples clustered identically (Extended Data Fig. 4b ).
We determined that, despite the instrument's high error rate, use of electrical current information meant that 25-fold read coverage of genome positions was sufficient to determine accurate genotypes (Extended Data Fig. 5 ). 
Letter reSeArCH
After deployment of the genome surveillance system, we worked in partnership with diagnostic laboratories in Guinea to provide real-time sequencing results to National Coordination in Guinea and the World Health Organisation (WHO). Collaborating laboratories provided leftover diagnostic RNA extracts for sequencing. The genome sequencing workflow, including amplification, sequence library preparation and sequencing could be accomplished within a working day. In one case, including remote bioinformatics analysis, the fastest time from patient sample to answer was achieved in less than 24 h (Supplementary Table 1 ), although the protocol was more usually performed over two working days. We found that in half of cases, we were able to generate sufficient reads on the MinION (between around 5,000 and 10,000) in less than an hour (Extended Data Fig. 6 ). In total, 142 samples were sequenced over 148 MinION runs during the 6-month period, providing extensive coverage of reported cases in the outbreak (Fig. 2 ). Full details of samples and runs are in the Supplementary Data. We failed to generate amplicons for some samples, resulting in missing regions of the genome. Such samples often corresponded to those with a high RT-PCR cycle threshold (C t ) value, suggestive of lower viral loads (Extended Data Fig. 7 ). For these we used a modified RT-PCR scheme using 19 shorter amplicons. We assumed that difficulties generating long amplicons related to low numbers of starting molecules of that length in the original sample. We excluded 17 samples owing to quality control issues, for example single nucleotide polymorphism (SNP) calling sensitivity of less than 75%. We found that in-field performance of the system was comparable with validation experiments performed in the UK, suggesting that the system tolerated transportation well (Extended Data Fig. 8 ).
We combined our sequencing data set with 603 samples from other studies and inferred a time-scaled phylogenetic tree using the BEAST software package ( Fig. 3) . A maximum likelihood analysis and rootto-tip analysis showed good agreement between sampling date and root-to-tip divergence (Extended Data Figs 9 and 10a). We estimated a substitution rate of 1.19 × 10 −3 (95% interval, 1.09 × 10 −3 , 1.29 × 10 −3 ) of the combined data set (Extended Data Fig. 10b ). This is consistent with rates from previous studies [2] [3] [4] [5] [6] [7] . Results generated within the first 10 days of starting real-time sequencing indicated that the persisting Guinean cases belonged to two major lineages, named GN1 and SL3, that had been established near the beginning of the epidemic (Fig. 3 ). Lineage GN1 is deeply branching from early cases in Guinea and has been infrequently seen in Sierra Leone 2 , suggesting that it has been largely confined to Guinea. The second lineage identified here was derived from lineage SL3 which was first detected in Sierra Leone by Gire et al. 2 , but was later seen circulating in Conakry towards the end of 2014 3 . Through integration of our data set with those generated by a different group operating in Sierra Leone we detected that both GN1 and SL3 had also been seen in Sierra Leone early in 2015, suggestive of transmission between the countries 17 .
This work demonstrates a step change in our ability to perform genomic surveillance prospectively during outbreaks under resource-limited conditions. However, numerous obstacles remain before such genomically informed investigations are routine. In practical terms, we encountered significant logistical issues when performing this work, notably the absence of reliable, continuous mains electrical power, forcing a dependence on unreliable electrical generators and uninterruptable power supply (UPS) units, particularly for the bulky PCR thermocyclers. However, portable, battery-powered thermocyclers are in development, and isothermal approaches may be preferable for future work 18 . By contrast, the MinION sequencer was unaffected by power outages and surges. We faced consistent issues with internet connectivity, which is currently required for analysis. There is a pressing need for a fully offline version of the analysis presented here. This would reduce the dependence on high bandwidth connections. However it is likely that phylogenetic analysis will continue to be performed remotely (discussed further in the supplementary Field Guide to Portable Sequencing). In this analysis we focused on variant calling approaches. A de novo approach to analysis would be preferable, but this would currently result in insertion and deletion errors due to poor resolution of homopolymeric tracts on the MinION. Our approach relies on amplification of genetic material before sequencing. In other epidemics, where the causative pathogen may be unidentified this is a drawback due to the need to have a priori knowledge of the pathogen genome sequence. In this event, sequencing directly from clinical material may be better, although sensitivity issues persist 15 .
Real-time genomic surveillance is a new tool in our arsenal to assist difficult epidemiological investigations, and to provide an international and environmental context to emerging infectious diseases. This may improve the efficiency of resource allocation and the timeliness of epidemiological investigations through genomically informed investigations of transmission chains. Real-time genomic surveillance also increases the possibility of identifying previously unknown chains of transmission. By integrating in real time our data set with that of a second group performing sequencing in Sierra Leone, we identified evidence of frequent transmissions across the border with Guinea. Crucially, we released data at regular intervals throughout this project through Github, integrating our results with those of others, displayed interactively at http://ebola.nextstrain.org. We employed the Virological web forum to discuss complex cases (http://virological.org). This system will continue to support the West African epidemic response and will serve as a template for genomic surveillance of future outbreaks.
The Ebola epidemic was officially declared to be over on 14 January 2016 (http://www.who.int/mediacentre/news/releases/2016/ebolazero-liberia/en/). Hours later, a new case of EVD was confirmed in Sierra Leone (http://who.int/mediacentre/news/statements/2016/ new-ebola-case/en/), confirming warnings that further flare-ups may be expected. Such cases pose pressing questions about their source that may be answered through genomic surveillance, by determining links to previously infected individuals 19 and ruling out a new zoonotic spillover event. We now stand poised to answer such questions quickly. 
MethOdS Ethics statement. The National Committee of Ethics in Medical Research of Guinea (permit no. 11/CNERS/14) approved the use of diagnostic leftover samples and corresponding patient data for this study. As the samples had been collected as part of the public health response to control the outbreak in West Africa, informed consent was not obtained from patients. Transportation. All equipment was loaded into a Pelican 1610 case (Pelican, Torrance, USA), cold chain reagents were packed into two polystyrene boxes with either ice or cool packs. These were sealed and placed in a holdall with the plastic consumables. Both pieces of luggage were flown by air as normal checked baggage. RNA extraction. RNA was extracted from 50 μ l whole blood, 140 μ l serum, 140 μ l of resuspended swab or 140 μ l urine using the QIAamp Viral RNA Mini Kit (Qiagen, Manchester, UK), following the manufacturer's instructions. Samples were inactivated by adding 560 μ l of Buffer AVL (Qiagen) and 560 μ l of 100% ethanol while still in a glove box, this method has been shown to inactivate EBOV in blood samples 20 The flowcell was primed with a blank sample created as described above, and left to incubate for 10 min. The priming process was repeated a second time before the sample was loaded. Running MinKNOW version 0.49.2.9 and starting the protocol 'MAP_48Hr_Sequencing_Run.py' initiated the sequencing run. An offline-capable version of MinKNOW, with internet 'ping' disabled and online updates disabled was made available to us by Oxford Nanopore Technologies specifically for the project (available on request from Oxford Nanopore Technologies 14, 1.24 and 1.34 ). This software was provided by Oxford Nanopore Technologies (available on request) for the project in order to permit basecalling to be carried out through the Linux command line as part of a pipeline. The MinION generates one direction (1D) and two direction reads (2D). 2D reads are higher quality and were used for analysis. 2D reads that were in the pass filter folder and 2D reads designated as high-quality (due to having more complement events than template events) in the fail folder as determined by poretools were extracted into FASTA (for nanopolish) and FASTQ format (for marginAlign) with poretools version 0.5.1 21 . Bioinformatics analysis. We use a reference mapping approach to detect single nucleotide variants through alignment to a reference strain from early in the outbreak (GenBank accession number EM_079517) 11 . Due to the nature of the sequencing data, which is dominated by insertion and deletion errors, we do not attempt to call insertion or deletions 14 . Variants were detected using the variants module of the nanopolish software package. Initial nucleotide base alignment was carried out with MarginAlign 12 . Nanopolish then uses the event-level ('squiggle') data generated by the MinION to evaluate candidate variants found in the aligned reads as described in the following section. Variants with a log likelihood ratio of >200 and coverage depth of >50× (25× 2D coverage) are accepted and a consensus sequence is generated for each sample. Regions of uncertainty (for example in difficult to sequence homopolymeric regions or primer binding sites), or with low coverage (< 50× , or 25× 2D coverage) are masked with an N character.
Assuming sufficient genomic coverage is present over a specific amplified variant this approach gives a high true positive variant calling rate. However, failure of individual amplicons to amplify, or unbalanced coverage of regions may reduce this figure. This is assessed, on each individual sample, by artificially mutating the reference genome with 30 randomly chosen mutations. Mutated positions in the references should be detected as variants, using the simplifying assumption that these variants are unlikely to be present in the sample. Any positions not covered by the tiling amplicon scheme (that is, the extreme 5′ and 3′ ends) are not considered in the true positive rate calculation. Each sample is therefore assigned a quality indicator. Those with a true positive rate (TPR, that is, sensitivity) of ≥ 75% are included in phylogenetic inferences. Samples with TPR < 75% were not used for the phylogenetic analysis presented here. Signal-based SNP calling. SNPs were called using the "variants" module from the nanopolish package (manuscript in preparation, https://github.com/jts/nanopolish, branch snp_calling_alternative_models, commit ID 25ea7bac3ab9e1d266079ac 105ab2005cfa39a14). The nanopolish variants program first finds candidate SNPs by finding mismatches between the aligned nanopore reads and the reference genome. These candidate SNPs are clustered into sets of nearby SNPs, an exhaustive set of candidate haplotypes are derived from the possible combinations of SNPs and the haplotype that maximizes the probability of the event-level data called as the sequence for region. We describe each step in detail below. Candidate SNP generation. We iterate over the entire reference genome and examine positions covered by at least 20 nanopore reads. At these well-covered positions we considered any non-reference base that was seen in at least 20% of the nanopore reads to be a candidate SNP. These candidates were passed to the next stage of the pipeline. Candidate haplotype generation. As the MinION sequencer does not measure single bases, but rather current signals dependent on a short sequence of nucleotides that are in the pore, we could not assess each SNP individually. Instead, we partitioned the set of candidate SNPs into groups whose signals may interact and overlap. We determined that SNPs separated by at least 10 bp could be treated independently; therefore we partitioned the candidate SNP set into subsets of SNPs that are within 10 bp of each. For each subset of candidate SNPs we exhaustively generated all possible haplotype sequences by including/excluding the individual SNPs in the subset. As the number of possible combinations of n SNPs is 2 n , we had to discard subsets that contained more than 10 candidate SNPs or spanned a reference region greater than 100 bp. For each derived haplotype sequence S, we calculate the likelihood of S using a modified version of the hidden Markov model (HMM) we previously described 16 . Haplotype likelihoods. The nanopolish HMM calculates the probability of observing a sequence of events emitted by the nanopore, which we denote as D, given an arbitrary sequence S. The structure of the HMM is as previously described but now allows events to be "soft-clipped" to better handle uncertainty about where the event-to-sequence alignment starts and ends. In addition, we incorporated a new model from Oxford Nanopore that models the event signals to be dependent on six-base-pair subsequences rather than five-base-pair subsequences. To use this model on SQK-MAP-005 data we calculated a global shift parameter (shift_offset) that rescales SQK-MAP-005 data to the 6 bp emission functions. We otherwise did not train the emission functions, per-read scaling parameters or transition probabilities of our hidden Markov model.
Variant calls. For each subset of candidate SNPs, the haplotype with the largest likelihood is called as the sequence for the region. The SNPs contained on the called haplotype (if any) are output in VCF format. The log likelihood ratio between the called haplotype and the reference haplotype (containing no SNPs) was output as the score for each variant to facilitate downstream filtering. Metadata such as the total depth of the region and the number of reads that support the called haplotype over the reference sequence is also output. Validation experiments. Dstl amplicons. Archived Zaire Ebolavirus was amplified using 38 primer pairs, giving approximately 500 base pair amplicons, according to the study protocol. As this work was before in-field sequencing, different versions of the MinKNOW software and Metrichor basecaller were used. Amplicons were sequenced by both MinION and Illumina. An Illumina library was constructed from the same amplicon pool and tagmented using the Nextera XT library preparation kit. The library was sequenced on the Illumina MiSeq. Because of the huge excess of coverage generated, this data set was subsampled to 400,000 paired reads before aligning to the EM_079517 reference sequence using BWA-MEM 22 . After sorting and converting the resulting alignment to BAM using samtools, variants were determined using FreeBayes 23 . A consensus sequence was generated using the vcf2fasta component of vcflib (https://github.com/ekg/vcflib). The MinION data was analysed as per the study methods, except for a modification to nanopolish to allow it to consider up to 15 variants per segment in order to account for the increased divergence between the genome and the reference. The MinION and Illumina consensus sequencs were aligned using the nucmer component of MUMMER and variants determined using the show-snps module 24 . Scripts and documentation for this analysis are in the Github notebook Dstl validation.ipynb. 180 genome analysis. Six samples of leftover RNA from a previously performed sequencing study 3 were processed at Public Health England Porton Down, as per the methods described in the manuscript. One sample did not yield any sequenceable products, so five genomes (EM_076534, EM_076533, EM_076383, EM_078416, EM_076769) were sequenced on MinION at PHE Porton Down. The 11 reaction scheme was used except for sample EM_076769 when the 19 reaction scheme was used. These sequences were compared with Illumina consensus sequences from the previously published data set in Carroll et al. 3 . Variants were identified between the reference genome (EM_079517) and each of the successfully samples using the show-snps component of MUMMER 24 . Variants detected by our pipeline were compared against expected variants, before and after quality filtering, using custom Python scripts deposited in the Github repository and documented in the IPython Notebook. A phylogeny was inferred using RaXML 25 including the consensus sequences from the validation set along with all of the consensus sequences from Carroll et al. 3 MinION sequence accuracy rates for two-direction (2D) reads were determined using A. Quinlan's count-errors.py script (http://github.com/arq5x/nanopore-scripts) as described in Quick et al. 11 . Scripts and documentation for this analysis are in the Github notebook: Examine validation runs.ipynb. Analysis of SNP calling sensitivity. Reads were subsampled at collection time intervals using the poretools times command 21 , simulating the order reads are obtained by real-time sequencing on the nanopore, to demonstrate the effect of coverage on SNP calling sensitivity and log likelihood ratio. Analysis of samples from the same patient. Samples were analysed as part of the real-time surveillance work. The consensus sequences from four pairs of samples each from four individuals were generated. Each pair was compared individually using the show-snps module of MUMmer to investigate differences.
Detection of putative transmission events from Sierra Leone. We downloaded the 74 genome sequences made available on http://virological.org (http://virological. org/t/direct-deep-sequencing-in-sierra-leone-yields-73-new-ebov-genomes-fromfebruary-may-2015/134) and aligned them against sequences from our analysis using MUSCLE 26 . We then generated a phylogenetic tree using FastTree 2 with the GTR model 27 . Any sequences that fell into the GN1 or SL3 lineages were included in future analysis. Phylogenetic inferences. Consensus sequences from real-time sequencing were aligned with previously published genome sequences from Guinea, Sierra Leone and Liberia 7 . To address the over-representation of Sierra Leone sequences in this set we randomly down-sampled available sequences, resulting in a total of 313 sequences from Sierra Leone. Maximum likelihood trees are produced using RAxML 8.2.3 using the GTRGAMMA model and 200 bootstrap replicates 25 . Timescaled trees were produced with BEAST v1.8.2 28 using a HKY+ gamma substitution model 29, 30 partitioned by first, second and third codon positions and intergenic regions, a Skygrid tree prior 31 and an uncorrelated lognormal clock 32 , and an uninformative prior on the mean of the molecular clock rate (XML file in the accompanying Github repository). The maximum clade credibility tree was recovered using TreeAnnotator. Phylogenetic trees were annotated using the ete3 Python package. Code availability. Reproducible workflows for the analysis presented here and consensus sequences can be found at http://github.com/nickloman/ebov and are freely available under the MIT license. The complete set of bioinformatics scripts are available in a Github repository with associated IPython Notebooks to regenerate the figures and tables presented in this manuscript can be found at http://github.com/nickloman/ebov. 

